UnitedHealth Group (UNH) PT Raised to $300 at Oppenheimer

Oppenheimer analyst Michael Wiederhorn raised the price target on UnitedHealth Group (NYSE: UNH) to $300.00 (from $295.00) while maintaining a Outperform rating.

The analyst commented, "UnitedHealth Group hosted its annual investor day, detailing the underlying strength of its solid FY2019 adj-EPS guidance of $14.40-$14.70 (OPCO/Street prior: $14.49/$14.58E), which falls in line with its long-term EPS target growth rate of 13-16%. The company also reiterated its FY2018 outlook, which includes adj-EPS approaching $12.80/shr based on $226B in revs (prev: $223-$225B). Following the release of the guidance and the investor day, we are maintaining our FY2018 EPS estimate of $12.79, but raising our FY2019 EPS estimate to $14.57 from $14.49 and our price target to $300 from $295."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
• Freedom Broker Upgrades Serve Robotics (SERV) to Buy